These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7281940)

  • 21. [Alcoholic and nonalcoholic liver steatosis].
    Mazur W
    Pol Arch Med Wewn; 2001; 105 Suppl():425-8. PubMed ID: 12412281
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute hepatic steatosis. Description of a clinical case of sodium valproate-induced acute hepatic steatosis].
    Coraggio F; Angiulli B; Carbone M; Catalano A; Costa MR; Gargiulo L; Gentile B; Masetto O; Pomponio N; Scarpato P
    Clin Ter; 1988 Mar; 124(6):451-63. PubMed ID: 2974353
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.
    Itoh S; Yougel T; Kawagoe K
    Am J Gastroenterol; 1987 Jul; 82(7):650-4. PubMed ID: 3605026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Liver steatosis. II: Microvesicular steatosis].
    Causse X; Gargot D; Michenet P
    Gastroenterol Clin Biol; 1995 Jan; 19(1):66-75. PubMed ID: 7720993
    [No Abstract]   [Full Text] [Related]  

  • 26. Some novel insights into the pathogenesis of alcoholic steatosis.
    Lakshman MR
    Alcohol; 2004 Aug; 34(1):45-8. PubMed ID: 15670665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
    Jepsen P; Vilstrup H; Mellemkjaer L; Thulstrup AM; Olsen JH; Baron JA; Sørensen HT
    Hepatogastroenterology; 2003; 50(54):2101-4. PubMed ID: 14696473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans.
    Jun DW; Han JH; Jang EC; Kim SH; Kim SH; Jo YJ; Park YS; Chae JD
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):667-72. PubMed ID: 19262398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of clinical efficiency of essential phospholipids and silymarin combination in nonalcoholic and alcoholic steatohepatitis].
    Iakimchuk GN; Gendrikson LN
    Eksp Klin Gastroenterol; 2011; (7):64-9. PubMed ID: 22364002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NAFLD and cardiovascular risk: direct evidence for the tale of two ages.
    Lonardo A; Loria P
    Am J Gastroenterol; 2009 Jul; 104(7):1851-2. PubMed ID: 19574981
    [No Abstract]   [Full Text] [Related]  

  • 32. The Possibility of differentiation between nonalcoholic steatohepatitis and fatty liver in rabbits on Gd-EOB-DTPA-enhanced open-type MRI scans.
    Sonoda A; Nitta N; Ohta S; Nitta-Seko A; Tsuchiya K; Nagatani Y; Mukaisho K; Takahashi M; Murata K
    Acad Radiol; 2011 Apr; 18(4):525-9. PubMed ID: 21237679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nonalcoholic steatohepatitis (NASH): therapeutic approaches].
    Buscher HP
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S60-2. PubMed ID: 15368170
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatty liver: how frequent is it and why?
    Bedogni G; Bellentani S
    Ann Hepatol; 2004; 3(2):63-5. PubMed ID: 15257248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heterogeneous steatosis. Echographic aspects].
    Scherrer A; Menu Y; Pariiente A; Laissy JP; Grenier P; Nahum H
    J Radiol; 1984 Jan; 65(1):25-9. PubMed ID: 6699799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunohistochemical studies on the occurrence of HBs antigen in alcoholic fatty liver and alcoholic fatty liver hepatitis].
    Thaler H; Beham A
    Wien Klin Wochenschr; 1986 Mar; 98(5):151-5. PubMed ID: 3515768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenesis, clinical aspects and development of fatty liver].
    Eitel B; Kleine FD; Kleine S
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(3):111-6. PubMed ID: 4042954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathomechanism of Zieve's syndrome--observation of patients treated at the Infectious Disease Clinic, Medical Academy, in Bydgoszcz].
    Halota W; Opoka J; Lapniewska E
    Przegl Epidemiol; 1989; 43(3):325-30. PubMed ID: 2616809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Glutathione in the treatment of chronic fatty liver diseases].
    Dentico P; Volpe A; Buongiorno R; Grattagliano I; Altomare E; Tantimonaco G; Scotto G; Sacco R; Schiraldi O
    Recenti Prog Med; 1995; 86(7-8):290-3. PubMed ID: 7569285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ["Alcoholic" liver damage in nonalcoholics. Nonalcoholic steatohepatitis].
    Dancygier H
    Dtsch Med Wochenschr; 1997 Sep; 122(39):1183-8. PubMed ID: 9378036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.